These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 37449209)

  • 1. A novel DNA damage repair-related gene signature predicting survival, immune infiltration and drug sensitivity in cervical cancer based on single cell sequencing.
    Xiang X; Kang J; Jiang J; Zhang Y; Zhang Y; Li L; Peng X
    Front Immunol; 2023; 14():1198391. PubMed ID: 37449209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of prognostic biomarkers for cervical cancer based on programmed cell death-related genes and assessment of their immune profile and response to drug therapy.
    Feng S; Wang Z; Zhang H; Hou B; Xu Y; Hao S; Lu Y
    J Gene Med; 2024 Jan; 26(1):e3643. PubMed ID: 38044747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
    Xu HH; Wang HL; Xing TJ; Wang XQ
    Front Immunol; 2022; 13():851622. PubMed ID: 35924232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of DNA Damage Repair Related Signature and Molecular Feature in Low-Grade Gliomas to Aid Chemotherapy and Drug Discovery.
    Yin X; Li M; He Z
    Front Biosci (Landmark Ed); 2023 Oct; 28(10):234. PubMed ID: 37919061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
    Li J; Tang LL; Ma J
    BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
    Sun K; Huang C; Li JZ; Luo ZX
    World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic stratification of sepsis through DNA damage response based RiskScore system: insights from single-cell RNA-sequencing and transcriptomic profiling.
    Lin Q; Zeng R; Yang J; Xu Z; Jin S; Wei G
    Front Immunol; 2024; 15():1345321. PubMed ID: 38404591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of tumor microenvironment and tumor immunology based on the double-stranded RNA-binding protein related genes in cervical cancer.
    Li J; Wan C; Li X; Quan C; Li X; Wu X
    J Transl Med; 2023 Sep; 21(1):647. PubMed ID: 37735483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a DNA damage repair-related LncRNA signature for predicting the prognosis and immunotherapy response of hepatocellular carcinoma.
    Huang F; Zhang C; Yang W; Zhou Y; Yang Y; Yang X; Guo W; Wang B
    BMC Genomics; 2024 Feb; 25(1):155. PubMed ID: 38326754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer.
    Guo Y; Bai Y; Wang L; Xu Z; Wang X; Wang W
    Medicine (Baltimore); 2022 Jul; 101(26):e29818. PubMed ID: 35777046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncover DNA damage and repair-related gene signature and risk score model for glioma.
    Wu Y; Liu L; Huang D; Li Z; Xu R; Cheng M; Chen L; Wang Q; You C
    Ann Med; 2023 Dec; 55(1):2200033. PubMed ID: 37086071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA signature mediates mitochondrial permeability transition-driven necrosis in regulating the tumor immune microenvironment of cervical cancer.
    Yi C; Yang J; Zhang T; Xie Z; Xiong Q; Chen D; Jiang S
    Sci Rep; 2024 Jul; 14(1):17406. PubMed ID: 39075098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene signatures, immune infiltration, and drug sensitivity based on a comprehensive analysis of m6a RNA methylation regulators in cervical cancer.
    Lu X; Li R; Ying Y; Zhang W; Wang W
    J Transl Med; 2022 Sep; 20(1):385. PubMed ID: 36058934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of ferroptosis-related molecular subtypes and a methylation-related ferroptosis gene prognostic signature in cervical squamous cell carcinoma.
    Yu L; Gao Z; Li Z; Liu P; Gao Y; Liang G
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14673-14689. PubMed ID: 37584713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune infiltration and a necroptosis-related gene signature for predicting the prognosis of patients with cervical cancer.
    Xing X; Tian Y; Jin X
    Front Genet; 2022; 13():1061107. PubMed ID: 36685937
    [No Abstract]   [Full Text] [Related]  

  • 16. Identify a DNA Damage Repair Gene Signature for Predicting Prognosis and Immunotherapy Response in Cervical Squamous Cell Carcinoma.
    Zhou H; Wu L; Yu L; Yang Y; Kong L; Liu S; Chen W; Li R
    J Oncol; 2022; 2022():8736575. PubMed ID: 35368888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
    Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA damage response-related signatures characterize the immune landscape and predict the prognosis of HCC via integrating single-cell and bulk RNA-sequencing.
    Li H; Shi Y; Li Y; Wu S; Yang R; Liu Q; Sun L
    Int Immunopharmacol; 2024 Aug; 137():112475. PubMed ID: 38909498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Perspectives Reveal the Role of DNA Damage Repair Genes in the Molecular Classification and Prognosis of Pancreatic Adenocarcinoma.
    Li Y; Zhang K; Peng L; Chen L; Gao H; Chen H
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a novel DNA damage repair-related long non-coding RNA signature in predicting prognosis, immunity, and drug sensitivity in uterine corpus endometrial carcinoma.
    Wang T; Ji M; Liu W; Sun J
    Comput Struct Biotechnol J; 2023; 21():4944-4959. PubMed ID: 37876625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.